Analyze Diet
Journal of clinical microbiology1997; 35(2); 531-535; doi: 10.1128/jcm.35.2.531-535.1997

Serologic markers in early stages of African horse sickness virus infection.

Abstract: Fifteen horses were experimentally infected with African horse sickness virus (AHSV) serotype 4. To learn more about the time course of production and specificity of AHSV-specific antibodies, sera were analyzed by immunoblot analysis. Only animals that survived for more than 9 days were able to develop a humoral immune response detectable by immunoblotting. The earliest serological markers corresponded mainly to VP5, VP6, and NS2 and to a lesser extent to VP3, NS1, and NS3. Neutralizing antibodies to VP2 were not detected by immunoblotting, suggesting that they are mostly conformation dependent. VP7-specific antibodies were detected later in infection. These results make NS2 and VP6 the most attractive candidates for the rapid diagnosis of the infection.
Publication Date: 1997-02-01 PubMed ID: 9003637PubMed Central: PMC229621DOI: 10.1128/jcm.35.2.531-535.1997Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research study explored the production and specificity of antibodies in horses infected with the African horse sickness virus (AHSV), aiming to identify which antibodies developed earliest and how this might assist with rapid diagnostic methods.

Introduction and Methodology

  • The study commenced with fifteen horses being experimentally infected with the AHSV serotype 4. The purpose of this infection was to further investigate the timeline and specificity of the AHSV-specific antibodies.
  • The researchers used a technique known as immunoblot analysis to evaluate the serum of the infected horses over time. This analysis was used to monitor the development and presence of specific antibodies in the blood.

Findings

  • The study found that horses that survived for beyond 9 days developed a noticeable humoral immune response, which was evident through immunoblotting, indicating the body’s immune system’s efforts to fight the virus.
  • The earliest detectable serological markers in the horse’s immune response to AHSV were primarily VP5, VP6, and NS2, with more minor markers seen for VP3, NS1, NS3.
  • Interestingly, neutralizing antibodies to VP2 were not detected in the study’s immunoblotting analysis. The researchers suggest this may point towards VP2 antibodies largely depending on the virus’s conformation—its three-dimensional structure—rather than simple exposure to the viral antigen.
  • Antibodies specifically targeting VP7 appeared later in the infection, indicating a delayed response to this particular viral protein.

Implications and Conclusion

  • The findings relevant to NS2 and VP6 antibodies could be significant for early diagnosis of the AHSV infection. Markers showing up early in the infection may be used as early warning signs of an AHSV infection, before it fully manifests.
  • Detailed understanding of the immune response timeline during the early stages of AHSV infection can serve as an essential tool in creating effective diagnostic methods, facilitating timely intervention and treatment.

Cite This Article

APA
Martínez-Torrecuadrada JL, Díaz-Laviada M, Roy P, Sánchez C, Vela C, Sánchez-Vizcaíno JM, Casal JI. (1997). Serologic markers in early stages of African horse sickness virus infection. J Clin Microbiol, 35(2), 531-535. https://doi.org/10.1128/jcm.35.2.531-535.1997

Publication

ISSN: 0095-1137
NlmUniqueID: 7505564
Country: United States
Language: English
Volume: 35
Issue: 2
Pages: 531-535

Researcher Affiliations

Martínez-Torrecuadrada, J L
  • INGENASA, Madrid, Spain.
Díaz-Laviada, M
    Roy, P
      Sánchez, C
        Vela, C
          Sánchez-Vizcaíno, J M
            Casal, J I

              MeSH Terms

              • African Horse Sickness / immunology
              • African Horse Sickness Virus / immunology
              • Animals
              • Antibodies, Viral / blood
              • Antigens, Viral
              • Blotting, Western
              • Capsid / immunology
              • Capsid Proteins
              • Vaccination
              • Viral Proteins / immunology
              • Viral Vaccines / immunology

              References

              This article includes 16 references
              1. Vet Res. 1993;24(2):199-212
                pubmed: 8102076
              2. J Gen Virol. 1993 Jan;74 ( Pt 1):81-7
                pubmed: 8423451
              3. Virology. 1994 Jul;202(1):348-59
                pubmed: 8009847
              4. J Virol Methods. 1994 Jul;48(2-3):245-56
                pubmed: 7989441
              5. Comp Immunol Microbiol Infect Dis. 1994 Aug-Nov;17(3-4):243-73
                pubmed: 8001348
              6. Virus Res. 1995 Oct;38(2-3):205-18
                pubmed: 8578859
              7. J Gen Virol. 1996 Jun;77 ( Pt 6):1211-21
                pubmed: 8683209
              8. Vet Microbiol. 1988 Mar;16(3):231-41
                pubmed: 2836995
              9. J Virol. 1990 Jan;64(1):1-8
                pubmed: 2152806
              10. J Gen Virol. 1990 Apr;71 ( Pt 4):793-9
                pubmed: 2324709
              11. J Virol Methods. 1991 Feb-Mar;31(2-3):285-92
                pubmed: 1864909
              12. J Gen Virol. 1992 Apr;73 ( Pt 4):925-31
                pubmed: 1378881
              13. J Virol Methods. 1992 Aug;38(2):229-42
                pubmed: 1517353
              14. Vet Microbiol. 1992 Nov;33(1-4):129-42
                pubmed: 1481352
              15. Vet Microbiol. 1992 Nov;33(1-4):143-53
                pubmed: 1481354
              16. Virology. 1993 Oct;196(2):799-803
                pubmed: 7690505

              Citations

              This article has been cited 5 times.
              1. Tinarwo M, Dennis SJ, Hitzeroth II, Meyers AE, Rybicki EP, Mbewana S. Development of an African horse sickness VP6 DIVA diagnostic ELISA. Virol J 2025 Aug 12;22(1):276.
                doi: 10.1186/s12985-025-02898-1pubmed: 40796889google scholar: lookup
              2. Fairbanks EL, Brennan ML, Mertens PPC, Tildesley MJ, Daly JM. Re-parameterization of a mathematical model of African horse sickness virus using data from a systematic literature search. Transbound Emerg Dis 2022 Jul;69(4):e671-e681.
                doi: 10.1111/tbed.14420pubmed: 34921513google scholar: lookup
              3. Karamalla ST, Gubran AI, Adam IA, Abdalla TM, Sinada RO, Haroun EM, Aradaib IE. Sero-epidemioloical survey on African horse sickness virus among horses in Khartoum State, Central Sudan. BMC Vet Res 2018 Aug 1;14(1):230.
                doi: 10.1186/s12917-018-1554-5pubmed: 30068335google scholar: lookup
              4. Mathebula EM, Faber FE, Van Wyngaardt W, Van Schalkwyk A, Pretorius A, Fehrsen J. B-cell epitopes of African horse sickness virus serotype 4 recognised by immune horse sera. Onderstepoort J Vet Res 2017 Feb 24;84(1):e1-e12.
                doi: 10.4102/ojvr.v84i1.1313pubmed: 28281773google scholar: lookup
              5. Chiam R, Sharp E, Maan S, Rao S, Mertens P, Blacklaws B, Davis-Poynter N, Wood J, Castillo-Olivares J. Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA). PLoS One 2009 Jun 22;4(6):e5997.
                doi: 10.1371/journal.pone.0005997pubmed: 19543394google scholar: lookup